{
  "ptid_time": "035_S_6660_2019-02-04",
  "img_path": "/data/qiuhui/data/adni/images/035_S_6660/2019-02-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 31,472 mm³, 14.9% below the reference mean. With a Z-score of -0.40 (34.4th percentile), this represents normal volume ; hippocampal volume measures 4,119 mm³, 36.6% below the reference mean. With a Z-score of -2.93 (0.2th percentile), this represents significant atrophy; whole brain volume measures 768,691 mm³, 17.2% below the reference mean. With a Z-score of -2.06 (2.0th percentile), this represents significant atrophy; entorhinal cortex volume measures 1,847 mm³, 46.7% below the reference mean. With a Z-score of -2.52 (0.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 10,449 mm³, 35.1% below the reference mean. With a Z-score of -2.64 (0.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 14,443 mm³, 19.9% below the reference mean. With a Z-score of -1.77 (3.8th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 84.9 years. Gender is Female. Education: 16 years. MMSE: 20.0. MoCA: 8.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.23 SUVR (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The patient shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus) and moderate-to-severe whole-brain atrophy, consistent with neurodegenerative disease. The cognitive scores (MMSE 20, MoCA 8) indicate substantial impairment, and the absence of APOE4 does not rule out Alzheimer's given the imaging and clinical profile.  \n\nDiagnosis: **Dementia** (likely Alzheimer’s disease given the pattern of atrophy and AV45 positivity).  \nConfidence: **High** (due to concordance between structural atrophy, cognitive deficits, and amyloid biomarker).",
  "timestamp": "2025-07-26T06:00:27.853930"
}